Anorexia clinical trials
The registry lists 163 studies for Anorexia across more than 10 countries. 25 are recruiting or about to start. 70 of them are mainly about Anorexia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.
Get an email when these change. Save the Anorexia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
M.D. Anderson Cancer Center (8) · Pfizer (5) · University College Dublin (4) · Alliance for Clinical Trials in Oncology (4) · University of Minnesota (3) · Bristol-Myers Squibb (3) · Mayo Clinic (3) · Wake Forest University Health Sciences (3)
What is being tested here
Drugs under test in Anorexia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Olanzapine | 2 | 4 | 5 |
| Ponsegromab | 2 | 1 | 5 |
| Megestrol Acetate | 1 | 6 | 12 |
| Megestrol | 1 | 6 | 12 |
| Ketamine | 1 | 0 | 1 |
| Rilogrotug | 1 | 1 | 1 |
| Donepezil | 1 | 0 | 1 |
| Fecal microbiota | 1 | 0 | 1 |
| Visugromab | 1 | 1 | 1 |
| Mirtazapine | 0 | 0 | 4 |
Drug classes tested here Antipsychotics 2 open · Serotonin receptor agonists 3
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Dec 2026Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer · Phase 3 · M.D. Anderson Cancer Center
- Sep 2027Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chemoradiotherapy-Related Anorexia in Nasopharyngeal Carcinoma · Phase 3 · Sun Yat-sen University
- Nov 2026A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of SXRN Injection in Patients With Cancer Cachexia · Jiangsu Nutai Biologics Co., Ltd
- Feb 2027Feasibility Study for Repurposing RET Inhibitors · University of Oklahoma
- Jun 2027Ketamine Effects on Learning In Eating Disorders · Amanda Downey, MD
- Jun 2027Fecal Microbiota Transplant for Anorexia Nervosa · Hamilton Health Sciences Corporation
- Jun 2027Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer · OHSU Knight Cancer Institute
- Jun 2027A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms · Shanghai Hutchison Pharmaceuticals Limited
- Jun 2027Secretin in Refeeding · University of California, Los Angeles
- Sep 2027Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy · Nanfang Hospital, Southern Medical University
Who these studies take
Of the 12 Anorexia studies recruiting now, 6 (50%) set no upper age limit and 6 (50%) stop at 75 or younger. 3 (25%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (17%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 9 (75%) | 9 (75%) |
| 30 | 8 (67%) | 8 (67%) |
| 40 | 8 (67%) | 8 (67%) |
| 50 | 8 (67%) | 8 (67%) |
| 65 | 9 (75%) | 9 (75%) |
| 75 | 8 (67%) | 8 (67%) |
| 85 | 6 (50%) | 6 (50%) |
Across all 163 studies, recruiting or not: 44% stop at 75 or younger and 37% at 65; 31% take children; 13% are for women only and 1% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Anorexia studies take
Of 30 interventional studies with no phase under Anorexia, half reached primary completion within 21 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 21 mo8–44 · 30 studies | — | 21 mo8–46 · 28 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 11, 2026.
Newly registered1
Studies
Recruiting first, then most recently updated. Showing 50 of 163. Browse all 163 → or search them.
- Visugromab in Cachexia International TrialRecruitingNCT07112196Phase 2/314 countries
- Master Protocol for the Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or mNSCLCNot yet recruitingNCT07888075Phase 2/3
- An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia NervosaNot yet recruitingNCT06518941Phase 21 country
- Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chemoradiotherapy-Related Anorexia in Nasopharyngeal CarcinomaRecruitingNCT07796789Phase 31 country
- A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and FatigueRecruitingNCT06989437Phase 2/321 countries
- Ketamine Effects on Learning In Eating DisordersEnrolling by invitationNCT06736769Phase 21 country
- Effects of Synbiotic Supplementation on Gastrointestinal Symptoms, Appetite, and Nutritional Recovery in Patients After Autologous Bone Marrow TransplantNot yet recruitingNCT07845669Not applicable1 country
- A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight LossNot yet recruitingNCT07663630Phase 12 countries
- Study on the Prevention of Weight Loss Through Physical Activity Among Nursing Home ResidentsNot yet recruitingNCT07831733Not applicable1 country
- Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung CancerRecruitingNCT05705492Phase 21 country
- Impact of Auditory Stimulation in Eating Pleasure (EDERE 2021)RecruitingNCT049230871 country
- Fecal Microbiota Transplant for Anorexia NervosaNot yet recruitingNCT06593366Not applicable
- Pediatric Prolonged-Release Melatonin for Sleep Disturbances in Children and Adolescents With Anorexia Nervosa (MELSom-ANOREXIA)Not yet recruitingNCT07576764Phase 31 country
- Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and ImmunotherapyNot yet recruitingNCT07565415Phase 21 country
- Secretin in RefeedingRecruitingNCT052358671 country
- Biolizin for Improving Functional Poor Appetite in Children Aged 6 to 36 Months (CTBE2502)RecruitingNCT07153549Not applicable1 country
- Feasibility Study for Repurposing RET InhibitorsNot yet recruitingNCT07146893Early Phase 11 country
- A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of SXRN Injection in Patients With Cancer CachexiaRecruitingNCT07231120Phase 11 country
- The Effect of a Protective Oral Care Protocol Using Peppermint Oil MouthwashNot yet recruitingNCT07179094Not applicable
- A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive SymptomsRecruitingNCT067556711 country
- The Clinical Research of Auricular Magnet for Anorexia in ChildrenRecruitingNCT06619548Not applicable1 country
- Olanzapine for Cancer Related Anorexia-cachexia SyndromeRecruitingNCT06517199Phase 31 country
- Neurobehavioural and Cognitive Changes in Cancer Cachexia (CANCOG)RecruitingNCT061129641 country
- Insights Into Participating in Clinical Studies for AnorexiaNot yet recruitingNCT061460751 country
- Finding Treatments for Eating DisordersNot yet recruitingNCT05249140Not applicable1 country
- Body Composition in Adolescents With Anorexia NervosaCompletedNCT068007421 country
- Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung CancerActive, not recruitingNCT03637816Phase 2/31 country
- Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer PatientsActive, not recruitingNCT04939090Phase 31 country
- Ruxolitinib for Cancer CachexiaActive, not recruitingNCT04906746Early Phase 11 country
- Effects of Mirtazapine on Appetite in Advanced Cancer PatientsActive, not recruitingNCT00488072Phase 21 country
- Dexamethasone for Symptom Burden in Advanced Cancer PatientsActive, not recruitingNCT00489307Phase 21 country
- Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15CompletedNCT05546476Phase 211 countries
- Effect of GLP-1 Analogue ROSE-010 on Appetite in Overweight and Obese SubjectsCompletedNCT06621017Phase 21 country
- Impact of Oral Phosphorus Supplements on the 6-month Change in FGF23 Levels in Anorexic Adolescents Suffering From Undernutrition.CompletedNCT028121341 country
- Identifying Networks Underlying Compulsivity in Anorexia Nervosa for Targeting With NeuromodulationActive, not recruitingNCT06138782Not applicable1 country
- Efficacy Study of an Olfactory Stimulation Program for the Recuperation of Autobiographical Memories in AnorexiaCompletedNCT02297165Not applicable1 country
- Effectiveness of Hatha Yoga and From Feeling to Seeing the Body (FSB) in Female Adolescents and Young Adults With Eating Disorders.CompletedNCT07512479Not applicable1 country
- Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional DyspepsiaCompletedNCT06217393Phase 35 countries
- AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT)Active, not recruitingNCT04859296Phase 11 country
- Anamorelin Study for Advanced Pancreatic CancerTerminatedNCT04844970Phase 21 country
- Implementing FBT for Adolescent AN for Providers in Private PracticeCompletedNCT04428580Not applicable1 country
- Family Functioning and Adverse Side Effects of Family-based Therapy for Anorexia NervosaActive, not recruitingNCT060972471 country
- Effectiveness of Cyproheptadine Hydrochloride Against Appetite to Improve Children's Nutritional StatusCompletedNCT07006181Not applicable1 country
- Use of Medication to Improve Weight Loss in Suboptimal Early Responders to Behavioral TreatmentCompletedNCT03779048Phase 41 country
- Effectiveness of Cannabinoids on Appetite in SclerodermaCompletedNCT05416697Phase 31 country
- Circulating and Molecular Markers Involved in the Processes of Cachexia, Anorexia and Sarcopenia in Patients With NSCLCActive, not recruitingNCT068081131 country
- Evaluating Oral Nutritional Supplements on Children's Nutritional Status and Digestive Health in Vietnam.CompletedNCT05551637Not applicable1 country
- Virtual Reality at End-of-lifeCompletedNCT06149429Not applicable1 country
- APPETITE: Plant Protein and Exercise Solutions for the Prevention of Undernutrition in Older Adults.Active, not recruitingNCT05608707Not applicable3 countries
- Effectiveness of Bacillus Spore Probiotics in Reducing Constipation, Anorexia, and Slow Weight Gain in ChildrenCompletedNCT06154525Not applicable1 country